MES tumors are characterized by high NF1 expression, while PN tumors frequently exhibit PDGFRA mutations and contain tumor cells similar to oligodendrocyte progenitors and neural progenitors. The gene discussed is NF1; the disease is Meckel syndrome, type 1.